← Leaderboards
Bruce D Walker
Massachusetts General Hospital
$50,324,331
Attributed
$50,754,218
Total exposure
23
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$113,549,926 · 26
By mechanism
P30$69,300,692 · 5
R01$18,723,627 · 9
U01$10,469,338 · 1
R37$8,137,609 · 2
P01$3,871,802 · 4
U19$2,462,426 · 3
Top collaborators
- Darrell J Irvine2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- David T Scadden$62,181,067
- Andrew D Luster$52,151,359
- Raymond T Chung$38,306,004
- Schahram Akbarian$48,610,378
- M. Amin Arnaout$31,171,564
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsImmune ResponseResponseViralImmuneT-LymphocyteInfectionCellsAntigensVirusCd8b1 GeneEpitopesAcutePersonsChronicCytokineVaccinesAcquired Immunodeficiency SyndromeFundingCollaborationsProgramsGrantIn VitroClinical Research
Grant awards (121)
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs$420,000
R01 · FY2024 · AI · contact PI
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs$420,000
R01 · FY2023 · AI · contact PI
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs$420,000
R01 · FY2022 · AI · contact PI
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs$420,000
R01 · FY2021 · AI · contact PI
Administrative Core$907,518
P30 · FY2020 · AI · contact PI
Pathogenesis of Clade C HIV Infection$621,120
R37 · FY2020 · AI · contact PI
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs$420,000
R01 · FY2020 · AI · contact PI
Administrative Core$1,029,291
P30 · FY2019 · AI · contact PI
Pathogenesis of Clade C HIV Infection$621,120
R37 · FY2019 · AI · contact PI
Molecular networks of HIV-specific CD4 T cell help to B cells$435,869
R01 · FY2019 · AI · contact PI
Harvard University Center for AIDS Research$3,540,479
P30 · FY2018 · AI · contact PI
Administrative Core$756,128
P30 · FY2018 · AI · contact PI
Pathogenesis of Clade C HIV Infection$621,120
R37 · FY2018 · AI · contact PI
Molecular networks of HIV-specific CD4 T cell help to B cells$435,851
R01 · FY2018 · AI · contact PI
Harvard University Center for AIDS Research$3,540,479
P30 · FY2017 · AI · contact PI
Administrative Core$628,285
P30 · FY2017 · AI · contact PI
Pathogenesis of Clade C HIV Infection$621,120
R37 · FY2017 · AI · contact PI
Molecular networks of HIV-specific CD4 T cell help to B cells$435,833
R01 · FY2017 · AI · contact PI
Harvard University Center for AIDS Research$3,643,746
P30 · FY2016 · AI · contact PI
Pathogenesis of Clade C HIV Infection$638,470
R37 · FY2016 · AI · contact PI
Administrative Core$606,041
P30 · FY2016 · AI · contact PI
Molecular networks of HIV-specific CD4 T cell help to B cells$435,815
R01 · FY2016 · AI · contact PI
Harvard University Center for AIDS Research$4,137,237
P30 · FY2015 · AI · contact PI
Administrative Core$1,121,770
P30 · FY2015 · AI · contact PI
Pathogenesis of Clade C HIV Infection$569,894
R37 · FY2015 · AI · contact PI
T-cell-mediated targeting of therapeutics to HIV reservoirs$422,887
R01 · FY2015 · AI
Harvard University Center for AIDS Research$4,278,137
P30 · FY2014 · AI · contact PI
Pathogenesis of Clade C HIV Infection$1,047,550
R37 · FY2014 · AI · contact PI
Administrative Core$542,619
P30 · FY2014 · AI · contact PI
T-cell-mediated targeting of therapeutics to HIV reservoirs$436,887
R01 · FY2014 · AI
Harvard University Center for AIDS Research$3,238,711
P30 · FY2013 · AI · contact PI
Pathogenesis of Clade C HIV Infection$568,110
R37 · FY2013 · AI · contact PI
Administrative$471,322
P30 · FY2013 · AI · contact PI
Inhibition of HIV 1 Replication by Cytotoxic Lymphocytes$349,632
R01 · FY2013 · AI · contact PI
Harvard University Center for AIDS Research$4,195,217
P30 · FY2012 · AI · contact PI
Pathogenesis of Clade C HIV Infection$604,912
R37 · FY2012 · AI · contact PI
PD-1 expression and HIV specific T cell dysfunction$502,142
P01 · FY2012 · AI · contact PI
Administrative$502,117
P30 · FY2012 · AI · contact PI
Inhibition of HIV 1 Replication by Cytotoxic Lymphocytes$371,948
R01 · FY2012 · AI · contact PI
Adaptive immunity in acute HIV infection$361,193
P01 · FY2012 · AI · contact PI
Harvard University Center for AIDS Research$4,620,425
P30 · FY2011 · AI · contact PI
Administrative$674,209
P30 · FY2011 · AI · contact PI
Pathogenesis of Clade C HIV Infection$638,597
R37 · FY2011 · AI · contact PI
Adaptive immunity in acute HIV infection$626,718
P01 · FY2011 · AI · contact PI
PD-1 expression and HIV specific T cell dysfunction$503,475
P01 · FY2011 · AI · contact PI
Inhibition of HIV 1 Replication by Cytotoxic Lymphocytes$371,948
R01 · FY2011 · AI · contact PI
Harvard University Center for AIDS Research$3,480,242
P30 · FY2010 · AI · contact PI
Pathogenesis of Clade C HIV Infection$602,506
R01 · FY2010 · AI · contact PI
Administrative$509,100
P30 · FY2010 · AI · contact PI
Inhibition of HIV 1 Replication by Cytotoxic Lymphocytes$438,075
R01 · FY2010 · AI · contact PI
Adaptive immunity in acute HIV infection$383,134
P01 · FY2010 · AI · contact PI
PD-1 expression and HIV specific T cell dysfunction$273,786
P01 · FY2010 · AI · contact PI
Harvard University Center for AIDS Research$134,000
P30 · FY2010 · AI · contact PI
Harvard University Center for AIDS Research$3,412,002
P30 · FY2009 · AI · contact PI
Pathogenesis of Clade C HIV Infection$590,866
R01 · FY2009 · AI · contact PI
Administrative$476,138
P30 · FY2009 · AI · contact PI
Inhibition of HIV 1 Replication by Cytotoxic Lymphocytes$440,833
R01 · FY2009 · AI · contact PI
Adaptive immunity in acute HIV infection$333,441
P01 · FY2009 · AI · contact PI
PD-1 expression and HIV specific T cell dysfunction$276,956
P01 · FY2009 · AI · contact PI
Dynamics of CD4 Responses in Acute Hepatitis C Virus Infection$132,276
U19 · FY2009 · AI · contact PI
Harvard Medical School Center for AIDS Research$3,312,623
P30 · FY2008 · AI · contact PI
Pathogenesis of Clade C HIV Infection$573,658
R01 · FY2008 · AI · contact PI
HIV 1 specific T cell clones$366,256
R01 · FY2008 · AI · contact PI
Adaptive immunity in acute HIV infection$337,277
P01 · FY2008 · AI · contact PI
PD-1 expression and HIV specific T cell dysfunction$273,680
P01 · FY2008 · AI · contact PI
Dynamics of CD4 Responses in Acute Hepatitis C Virus Infection$129,397
U19 · FY2008 · AI · contact PI
Harvard Medical School Center for AIDS Research$3,191,306
P30 · FY2007 · AI · contact PI
Pathogenesis of Clade C HIV Infection$567,736
R01 · FY2007 · AI · contact PI
HIV 1 specific T cell clones$373,348
R01 · FY2007 · AI · contact PI
Dynamics of CD4 Responses in Acute Hepatitis C Virus Infection$134,081
U19 · FY2007 · AI · contact PI
HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN$127,482
N01 · FY2007 · AI · contact PI
Harvard University Center for AIDS Research$3,220,335
P30 · FY2006 · AI · contact PI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION$1,925,423
U01 · FY2006 · AI · contact PI
Immune Control and Evasion during Acute HCV Infection$849,555
U19 · FY2006 · AI · contact PI
Pathogenesis of Clade C HIV Infection$586,412
R01 · FY2006 · AI · contact PI
HIV 1 specific T cell clones$384,499
R01 · FY2006 · AI · contact PI
Inhibition of HIV1 Replication by Cytotoxic Lymphocytes$380,103
R01 · FY2006 · AI · contact PI
Dynamics of CD4 Responses in Acute HCV Infection$125,662
U19 · FY2006 · AI · contact PI
Harvard Medical School Center for AIDS Research$3,520,548
P30 · FY2005 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION$2,037,176
U01 · FY2005 · AI
Immune Control and Evasion during Acute HCV Infection$869,999
U19 · FY2005 · AI
HIV 1 specific T cell clones$393,750
R01 · FY2005 · AI
Inhibition of HIV1 Replication by Cytotoxic Lymphocytes$389,250
R01 · FY2005 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$346,000
R01 · FY2005 · AI
The impact of HIV viral diversity and cellular immunity on HIV pathogenesis$211,670
P30 · FY2005 · AI
Dynamics of CD4 Responses in Acute HCV Infection$127,448
U19 · FY2005 · AI
Administrative core$94,008
U19 · FY2005 · AI
Harvard Medical School Center for AIDS Research$3,012,520
P30 · FY2004 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION$2,264,709
U01 · FY2004 · AI
Harvard Medical School Center for Aids Research$414,792
P30 · FY2004 · AI
HIV 1 specific T cell clones$391,500
R01 · FY2004 · AI
Inhibition of HIV1 Replication by Cytotoxic Lymphocytes$389,250
R01 · FY2004 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$346,000
R01 · FY2004 · AI
Harvard Medical School Center for Aids Research$232,250
P30 · FY2004 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION$2,170,255
U01 · FY2003 · AI
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH$1,507,853
P30 · FY2003 · AI
IMMUNE CONTROL OF HIV REPLICATION$560,195
R01 · FY2003 · AI
HIV 1 SPECIFIC T CELL CLONES$424,863
R37 · FY2003 · AI
Inhibition of HIV1 Replication by Cytotoxic Lymphocytes$389,250
R01 · FY2003 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$346,000
R01 · FY2003 · AI
Development of a Microarray for CTL Detection$219,350
R21 · FY2003 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION$2,071,775
U01 · FY2002 · AI
IMMUNE CONTROL OF HIV REPLICATION$940,551
R01 · FY2002 · AI
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH$804,905
P30 · FY2002 · AI
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH$547,782
P30 · FY2002 · AI
Inhibition of HIV1 Replication by Cytotoxic Lymphocytes$389,250
R01 · FY2002 · AI
HIV 1 SPECIFIC T CELL CLONES$356,096
R37 · FY2002 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$346,000
R01 · FY2002 · AI
Development of a Microarray for CTL Detection$237,600
R21 · FY2002 · AI
HIV 1 SPECIFIC T CELL CLONES$117,438
R37 · FY2002 · AI
Core--Human immunology facility$0
P01 · FY2002 · AI
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH$1,427,882
P30 · FY2001 · AI
IMMUNE CONTROL OF HIV REPLICATION$539,652
R01 · FY2001 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$371,500
R01 · FY2001 · AI
HIV 1 SPECIFIC T CELL CLONES$347,682
R37 · FY2001 · AI
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH$1,451,013
P30 · FY2000 · AI
IMMUNE CONTROL OF HIV REPLICATION$727,493
R01 · FY2000 · AI
HIV 1 SPECIFIC T CELL CLONES$339,517
R37 · FY2000 · AI
INHIBITION OF HIV1 REPLICATION BY CYTOTOXIC LYMPHOCYTES$286,759
R01 · FY2000 · AI
HIV 1 SPECIFIC CD4 CELLS IN DISEASE PATHOGENESIS$268,863
R01 · FY2000 · AI
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTION$201,402
R01 · FY2000 · AI